Zobrazeno 1 - 10
of 239
pro vyhledávání: '"E.V. Shikh"'
Autor:
Yu.E. Dobrokhotova, A.A. Khryanin, E.V. Shikh, L.Yu. Karakhalis, I.M. Ordiyants, Kogan E.A, A.V. Yakimova, I.N. Korotkikh, N.I. Kokhno
Publikováno v:
РМЖ. Мать и дитя, Vol 6, Iss 2 (2023)
Yu.E. Dobrokhotova1, A.A. Khryanin2, E.V. Shikh3, L.Yu. Karakhalis4, I.M. Ordiyants5, E.A. Kogan1, A.V. Yakimova2, I.N. Korotkikh6, N.I. Kokhno7 1Pirogov Russian National Research Medical University, Moscow, Russian Federation 2Novosibirsk Stat
Externí odkaz:
https://doaj.org/article/94a28fc8c1a64d25853f1cb09567d92a
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 56 (2023)
The aim of this study was to determine how sacubitril/valsartan compared with valsartan in an outpatient setting affects left ventricular remodeling in heart failure with reduced ejection fraction and functional (or secondary) mitral regurgitation (S
Externí odkaz:
https://doaj.org/article/d4ed1835861f46f4ab4cac63947ca21f
Autor:
M.V. Makhova, E.V. Shikh, V.V. Strakhov, D.S. Blinov, G.K. Poluosmak, E.V. Semeleva, E.V. Blinova
Publikováno v:
РМЖ "Клиническая офтальмология", Vol 23, Iss 1 (2023)
M.V. Makhova1, E.V. Shikh2, V.V. Strakhov1, D.S. Blinov3,4, G.K. Poluosmak2, E.V. Semeleva5, E.V. Blinova2,4 1Yaroslavl State Medical University, Yaroslavl, Russian Federation 2I.M. Sechenov First Moscow State Medical University (Sechenov Unive
Externí odkaz:
https://doaj.org/article/0620a47171da41d897075c714cd88aa5
Autor:
E.V. Shikh, N.N. Eremenko
Publikováno v:
Вопросы современной педиатрии, Vol 7, Iss 1, Pp 137-139 (2008)
Nonsteroid anti-inflammatory medications are the basis of pharmacotherapy for the pain syndrome, which is accounted for their anti-inflammatory, analgesic and febrifuge effects. The existing data on the dangers experienced during the prolonged applic
Externí odkaz:
https://doaj.org/article/f4de39f041194704a42638fdbdbe829e
Autor:
E.V. Shikh
Publikováno v:
Педиатрическая фармакология, Vol 4, Iss 4, Pp 114-115 (2007)
Externí odkaz:
https://doaj.org/article/0cae2edb854f44b0a00e40cd96b3f2fc
Autor:
Pchelintsev M.V. Pchelintsev, Babak S.L. Babak, Shikh E.V. Shikh, Kalyuzhin O.V. Kalyuzhin, Esaulenko E.V. Esaulenko, Gorelov A.V. Gorelov, Malyavin A.G. Malyavin
Publikováno v:
Therapy. :144-151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04dbd36f07bd4e68a43141915542567d
https://doi.org/10.18565/therapy.2022.10.144-151
https://doi.org/10.18565/therapy.2022.10.144-151
Publikováno v:
Clinical pharmacology and therapy. 33:57-62
Irbesartan belongs to a group of angiotensin II receptor blockers that are used worldwide for the treatment of patients with hypertension, type 2 diabetes, and impaired renal function. Irbesartan can be administered alone or in combination with other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::428c80b739d13923b0e92a94097dca1f
https://doi.org/10.32756/0869-5490-2022-2-57-62
https://doi.org/10.32756/0869-5490-2022-2-57-62
Autor:
N.I. Stuklov, E.V. Shikh
Publikováno v:
Фармакология & Фармакотерапия. :16-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49c5d7f1a8f9c9186246e83a6fa90f1e
https://doi.org/10.46393/27132129_2022_4_16
https://doi.org/10.46393/27132129_2022_4_16
Autor:
Evgeniy Yu. NIKITIN, V.N. DROZDOV, O.A. VOROB'EVA, A.A. ASTAPOVSKY, K.N. KHALAIDZHEVA, E.V. SHIKH
Publikováno v:
Фармакология & Фармакотерапия. :60-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1aaeca218919439ecb6347cfdff3d4b8
https://doi.org/10.46393/27132129_2022_2_60
https://doi.org/10.46393/27132129_2022_2_60
Publikováno v:
Фармакология & Фармакотерапия. :58-63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db348df61faaedc1485d865456a12c2d
https://doi.org/10.46393/27132129_2022_4_58
https://doi.org/10.46393/27132129_2022_4_58